{
    "nct_id": "NCT06538480",
    "official_title": "A Phase 3 Trial of PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis in Adult Patients",
    "inclusion_criteria": "* Age 18 years and older\n* Clinical diagnosis of RRP requiring surgical intervention\n* Performance status of ECOG of 0-1\n* Sexually active participants (men and women) of reproductive potential must agree to use contraception.\n* All participants must have the ability to understand and willingness to sign a written informed consent\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Severe acute or chronic medical or psychiatric conditions that, in the opinion of the investigators, may increase the risk associated with study participation or study drug administration, impair the ability of the subject to receive protocol therapy, or interfere with the interpretation of study results and in the judgment of the investigator, would make the participant inappropriate for entry into this study.\n* Participants receiving any prohibited medications including immunosuppressive medications and other treatments for RRP.\n* Participants who had received any other investigational agents within the past 30 days.\n* Pregnant women are excluded from this study",
    "miscellaneous_criteria": "Key"
}